Exodus Point Capital Management, LP Immatics N.V. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Immatics N.V. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 24,437 shares of IMTX stock, worth $286,890. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,437
Previous 121,499
79.89%
Holding current value
$286,890
Previous $1.41 Million
81.73%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
85Shares Held
68.8MCall Options Held
507KPut Options Held
170K-
Rtw Investments, LP New York, NY10MShares$117 Million1.69% of portfolio
-
Wellington Management Group LLP Boston, MA8.33MShares$97.8 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$75.6 Million0.86% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.3MShares$74 Million0.04% of portfolio
-
Perceptive Advisors LLC New York, NY4.58MShares$53.8 Million1.01% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $895M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...